TS

Tempo Scan Pacific Tbk

TSPC · JK · Industrials / Conglomerates

2,230.00IDR+10.00 (+0.45%)

Price History

Full chart

Market Stats

Previous Close2,220.00
Open2,210.00
Day Range2,200.00 – 2,250.00
52-Week Range2,215.34 – 3,156.36
Volume1.58M
Market Cap12.09T
P/E (TTM)8.15
Forward P/E14.14
EPS328.99
Dividend Yield5.66%
Beta0.13
50-Day Avg2,748.20
200-Day Avg2,624.50

About

PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. The company operates through Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services segments. It is involved in the pharmaceutical and medical devices trading; manufacture of soaps, herbal products, powder milk, food and beverages, and plastic packaging; and manufacturing and trading of consumer products, cosmetics, and household products. The company sells its products under the Bodrex, Oskadon, Neo rheumacyl, Bodrexin, Contrexyn, Contrex, Oskadryl, Vidoran, Neodulax, Vidoran, Hemaviton, Neo Hormoviton, Polaris, Vitonal, Vitamin IPI, Neo rheumacyl Herbal, Wybert Herbal, Bodrexin Herbal, Herbalax, Marina, Natural Honey, Claudia, Total Care, and ULTIMA II brands. It also engages in the construction and rental of buildings; Trading, fresh milk processing, livestock, and agriculture; cosmetics retailer and e-commerce; advertising and promotion, research and development, and information technology and communication network systems services; and procurement, distribution, and marketing activities. The company was formerly known as PT Scanchemie. PT Tempo Scan Pacific Tbk was founded in 1970 and is based in Jakarta, Indonesia. The company operates as a subsidiary of PT Bogamulia Nagadi.

Company Details

  • SectorIndustrials
  • IndustryConglomerates
  • CEOMr. I Made Dharma Wijaya
  • Employees4.39K
  • HeadquartersTempo Scan Tower, Jakarta, Indonesia, 12950, Indonesia
  • Websitehttps://www.temposcangroup.com

Leadership

  • Mr. I Made Dharma WijayaPresident Director and MD of Sales & Operation - Distribution Division · b. 1970
  • Kartika Chandra SutantioCorporate Finance & Treasury Director
  • Ms. . ShaniaGroup General Counsel Director, Corporate Secretary & Director · b. 1974
  • Ms. Linda LukitasariResearch & Development Director and Director · b. 1967
  • Ms. Nina MuthmainnahManaging Director of International Business and License Cosmetics
  • F. Cisca DwijaniManaging Director of Prescription Medicine Group
  • Mr. Swasta KusnadiHead of Internal Audit · b. 1961
  • Mr. Galang Putra AriyantoHead of Internal Audit of Distribution Division · b. 1991

Financials

Income Statement

Currency: IDR2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.45T1.79T1.96T2.12T2.37T2.50T2.73T3.12T3.63T4.50T5.13T5.78T6.63T6.85T7.51T8.18T9.14T9.57T10.09T10.99T10.97T11.23T12.25T13.12T13.65T14.01T
Growth (%)-+22.98%+9.76%+8.41%+11.65%+5.33%+9.26%+14.47%+16.32%+23.78%+14.15%+12.59%+14.71%+3.38%+9.59%+8.91%+11.69%+4.68%+5.46%+8.98%-0.23%+2.43%+9.08%+7.06%+4.08%+2.57%
Cost of Revenue756.75B967.21B1.09T1.14T1.28T1.41T1.61T1.84T2.22T2.82T3.24T3.58T4.14T4.14T4.57T5.06T5.65T5.91T6.25T6.75T7.06T7.23T8.09T8.61T8.48T8.88T
Gross Profit-----1.08T1.12T1.28T1.41T1.68T1.89T2.20T2.49T2.72T2.94T3.12T3.48T3.66T3.84T4.24T3.91T4.01T4.16T4.51T5.18T5.13T
Gross Margin-----43.43%41.00%40.96%38.93%37.25%36.90%38.06%37.53%39.68%39.14%38.11%38.13%38.24%38.08%38.58%35.67%35.68%33.98%34.40%37.92%36.61%
Operating Expense-----731.34B804.88B959.03B1.05T2.12T1.30T1.54T1.75T1.96T2.26T2.43T2.79T3.02T3.14T3.44T2.84T2.90T3.44T3.26T3.37T3.53T
Operating Income354.55B329.24B374.89B370.96B374.61B353.48B314.04B320.56B363.37B-445.55B591.00B662.82B742.21B757.55B678.25B691.79B691.88B634.16B702.58B797.08B1.08T1.10T728.66B1.26T1.81T1.60T
Operating Margin24.42%18.44%19.13%17.46%15.80%14.15%11.51%10.26%10.00%-9.91%11.51%11.47%11.19%11.05%9.03%8.46%7.57%6.63%6.96%7.25%9.81%9.83%5.95%9.59%13.25%11.43%
EBITDA-----353.48B314.04B320.56B363.37B445.55B597.35B662.82B860.70B911.76B836.96B829.69B907.09B950.75B955.56B1.01T1.39T1.39T1.67T2.00T2.44T1.92T
EBITDA Margin-----14.15%11.51%10.26%10.00%9.91%11.63%11.47%12.98%13.30%11.14%10.14%9.93%9.94%9.47%9.23%12.70%12.35%13.63%15.23%17.89%13.73%
Net Income347.79B316.93B316.31B322.70B324.47B296.82B272.58B278.36B320.65B359.96B488.89B566.05B627.95B634.62B579.38B521.96B536.27B543.80B512.03B554.26B787.80B823.77B1.00T1.18T1.45T1.41T
Net Income Margin23.96%17.75%16.14%15.19%13.68%11.88%9.99%8.91%8.82%8.00%9.52%9.79%9.47%9.26%7.71%6.38%5.87%5.69%5.08%5.04%7.18%7.33%8.17%8.97%10.60%10.04%
R&D1.06B----384.03M------717.35M1.28B2.22B9.82B6.80B4.28B4.90B4.30B4.01B3.88B4.65B2.41B4.64B2.50B
R&D as % of Total Revenue0.07%----0.02%------0.01%0.02%0.03%0.12%0.07%0.04%0.05%0.04%0.04%0.03%0.04%0.02%0.03%0.02%
Interest Expense000004.29B3.85B3.06B3.06B3.81B7.24B8.63B6.93B7.30B11.87B8.43B9.95B25.82B31.26B51.20B51.71B52.10B69.87B83.06B74.87B69.74B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.17%0.14%0.10%0.08%0.08%0.14%0.15%0.10%0.11%0.16%0.10%0.11%0.27%0.31%0.47%0.47%0.46%0.57%0.63%0.55%0.50%

Balance Sheet

Currency: IDR2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.43T1.66T1.82T1.94T2.14T2.35T2.48T2.77T2.97T3.26T3.59T4.25T4.63T5.41T5.59T6.28T6.59T7.43T7.87T8.37T9.10T9.64T11.33T11.32T12.49T13.09T
Total Liabilities320.75B330.03B319.39B303.36B342.23B472.47B447.32B558.37B655.93B819.65B944.86B1.20T1.28T1.55T1.46T1.95T1.95T2.35T2.44T2.58T2.73T2.77T3.78T3.25T3.34T3.43T
Total Equity1.05T1.27T1.42T1.56T1.71T1.79T1.94T2.12T2.24T2.41T2.60T3.01T3.32T3.82T4.09T4.29T4.58T4.80T5.14T5.49T6.06T6.53T7.22T7.70T8.69T9.19T
Cash16.87B24.59B29.53B19.88B13.94B832.78B834.75B951.99B1.01T1.18T1.40T1.61T1.65T1.79T1.46T1.74T1.69T1.97T1.90T2.25T2.65T2.69T3.48T3.69T4.46T4.64T
Total Debt-----58.23B31.33B25.78B35.05B70.70B118.76B143.37B95.96B186.27B93.32B90.31B185.49B289.58B474.56B581.01B733.30B931.92B1.45T1.12T858.85B1.06T
Net Debt------774.55B-803.43B-926.21B-973.20B-1.11T-1.28T-1.47T-1.56T-1.61T-1.37T-1.65T-1.50T-1.68T-1.43T-1.71T-1.91T-1.76T-2.03T-2.58T-3.60T-3.58T

Cash Flow

Currency: IDR2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow363.23B338.10B341.92B320.77B424.90B297.70B234.89B294.71B292.30B476.59B578.09B587.80B635.03B448.67B501.51B778.36B491.66B562.48B441.13B889.78B982.70B689.65B1.19T1.20T1.71T1.42T
Investing Cash Flow------206.44B-59.74B-76.63B-35.81B-101.32B-85.00B-180.86B-219.41B-182.31B-392.27B-266.32B-387.05B-276.56B-435.28B-365.37B-388.56B-372.63B132.55B227.14B-333.59B-555.91B
Financing Cash Flow------193.34B-159.94B-121.04B-266.01B-154.00B-247.46B-194.71B-394.24B-260.37B-443.48B-298.57B-132.50B-11.62B-59.83B-150.25B-212.01B-317.34B58.86B-1.15T-772.07B-822.69B
Capital Expenditure31.51B44.69B102.68B105.58B116.47B200.18B90.98B83.91B75.45B124.53B110.41B202.99B210.61B421.97B403.56B262.33B388.27B389.06B466.22B328.69B447.84B385.87B592.17B326.65B393.06B551.21B
Free Cash Flow-----97.53B143.91B210.80B216.84B352.06B467.67B384.81B424.42B26.70B97.95B516.03B103.39B173.43B-25.09B561.09B534.86B303.78B601.16B872.81B1.32T866.35B
Dividends Paid22.50B112.50B135.00B180.00B180.00B189.80B135.00B112.50B270.00B180.31B292.50B215.25B260.84B260.78B261.01B223.67B176.07B177.09B143.26B144.40B183.47B295.45B291.68B578.17B397.06B811.47B
FCF to OCF-----32.76%61.27%71.53%74.19%73.87%80.90%65.47%66.83%5.95%19.53%66.30%21.03%30.83%-5.69%63.06%54.43%44.05%50.38%72.77%77.08%61.12%
Dividend Paid to FCF-----194.61%93.81%53.37%124.52%51.21%62.54%55.94%61.46%976.84%266.47%43.34%170.30%102.11%-571.06%25.74%34.30%97.26%48.52%66.24%30.04%93.67%

Earnings

Report DateMay 3, 2012Aug 30, 2012Oct 30, 2012Feb 27, 2013May 2, 2013Aug 29, 2013Nov 5, 2013Feb 26, 2014May 1, 2014Aug 28, 2014Nov 5, 2014Mar 31, 2015May 29, 2015Aug 27, 2015Oct 28, 2015Mar 31, 2016Apr 25, 2016Jul 29, 2016Oct 31, 2016Mar 31, 2017May 3, 2017Jul 31, 2017Oct 31, 2017Mar 30, 2018May 3, 2018Aug 30, 2018Oct 30, 2018Feb 27, 2019May 2, 2019Aug 29, 2019Nov 5, 2019Feb 26, 2020May 7, 2020Aug 27, 2020Nov 2, 2020Mar 3, 2021Apr 30, 2021Aug 31, 2021Oct 29, 2021May 31, 2022Aug 12, 2022Nov 16, 2022May 22, 2023
EPS Estimate-------------------------------------------
EPS Actual49.2541.7131.1217.4752.3343.0932.2813.3355.9935.9729.707.0951.5331.4032.520.5445.7129.8026.4217.2546.0929.1122.8722.7845.2430.0818.4620.0045.1828.3219.0530.6263.1319.2627.7564.9263.7627.2130.2259.9824.0235.86126.12
Surprise-------------------------------------------
Timing----------After-hoursAfter-hoursPre-market-Pre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market----------------Pre-marketAfter-hours-

Key Statistics & Ratios

Market Cap12.09T
Enterprise Value7.80T
Trailing P/E8.15
Forward P/E14.14
PEG Ratio0.44
Price / Sales0.83
Price / Book1.24
EPS328.99
Book Value2,159.21
Revenue (TTM)14.52T
Gross Profit (TTM)5.49T
EBITDA2.07T
Profit Margin10.19%
Operating Margin13.52%
Return on Equity15.39%
Return on Assets8.24%
Shares Outstanding4.51B
Shares Float396.96M
Beta0.13
Dividend Yield5.66%
Dividend Rate150.00
Payout Ratio45.77%

Dividends

20262×
75.00Nov 2, 202650.00Jun 17, 2026
20252×
100.00Nov 10, 2025100.00Jun 5, 2025
20242×
25.00Dec 3, 202475.00Jul 3, 2024
20232×
50.00Nov 10, 2023100.00Jun 13, 2023
20222×
25.00Dec 19, 202250.00Jun 10, 2022
20212×
20.00Dec 1, 202160.00Jul 6, 2021
20201×
50.00Jul 9, 2020
20191×
40.00Jun 11, 2019
20181×
40.00Jun 22, 2018
20171×
50.00Jun 13, 2017
20161×
50.00Jun 29, 2016
20151×
64.00Jun 11, 2015
20141×
75.00Jul 25, 2014
20131×
75.00Jul 8, 2013
20121×
75.00Jul 13, 2012
20111×
40.00Aug 4, 2011
20102×
30.00Nov 5, 201035.00Sep 3, 2010

Stock Splits

  • Sep 14, 200610:1